1 active not recruiting, 1 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Subjective Cognitive Impairment: new trials by email Literature Review of Subjective Cognitive Impairment trials Research Report on Subjective Cognitive Impairment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance. Turmeric extract, Control: Placebo. 500mg gelatin in capsules 2 times a day - Cognitive Decline, Subjective Cognitive Impairment | Phase 2 / Phase 3 | Active not recruiting | Instituto Mexicano del Seguro Social | 100 | 2025-02-20 | 2026-03-25 |
| Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems Memantine, Placebo - Memory Disorder, Retention Disorder, Cognitive | Phase 2 | Completed | Merz Pharmaceuticals GmbH | 299 | 2010-11-01 | 2013-11-27 |
Cognitive Dysfunction (1) · Insulin Resistance (1) · Memory Disorders (1)
Cognition Disorders (1) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Mental Disorders (1) · Metabolic Diseases (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurocognitive Disorders (1) · Neurologic Manifestations (1) · Nutritional and Metabolic Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Gelatin (1) · Memantine (1) · turmeric extract (1)
Instituto Mexicano del Seguro Social (1) · Merz Pharmaceuticals GmbH (1)
Germany (1) · Mexico (1) · United Kingdom (1)